Navigation Links
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
Date:7/8/2009

. "Then, in March 2008, we performed the first enlargement of the path blood follows as it exits the heart using the CorMatrix ECM, in lieu of a prosthetic device, for a patient undergoing valve surgery.

The first mitral valve reconstruction using CorMatrix occurred at St. Francis Heart Center as well, in October of 2008. Large defects had been created in a patient's valve by infection. The valve was restored to normal function using CorMatrix patches, avoiding a valve replacement.

"We have been able to make similar repairs for other patients since," added Gerdisch.

The CorMatrix ECM is derived from porcine small intestines and is processed in a way that removes all cells, leaving the complex structural matrix intact. Once surgically implanted, it serves as a scaffold, allowing the patient's cells to infiltrate and ultimately replace the ECM scaffold.

While the patient continues to heal, the matrix gradually is replaced as the body reinforces and remodels the tissue. In the past, tissue replacement has been limited by options for implantation.

Animal tissue implants are subject to calcium deposition and hardening, due to the body's ability to recognize them as foreign. Synthetic material lacks the performance characteristics of tissue and causes an inflammatory response. ECM, however, leads to growth of functional tissue where scarring would normally be expected.

More information about how the ECM is being used at St. Francis Hospital & Health Centers is at www.cardiactissuerepair.net.

About St. Francis Heart Center

Referring physicians wanting to learn more about heart valve surgery and Dr. Marc Gerdisch's work with ECM can call toll-free at 1-866-237-0565. The St. Francis Heart Center is dedicated to providing our patients with the region'
'/>"/>

SOURCE St. Francis Heart Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
2. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
3. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
6. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
7. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
8. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
9. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
10. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
11. Surgeon Generals Call to Action to Prevent DVT/PE Praised by NATT as Turning Point

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...PRNewswire/--ACUOTECHNOLOGIES,developersofhigh-per...ontoolsandservices,ispleasedtoannouncethattheUnite...pplicationforan"AssetCommunicationFormatwithinaCom....patenttoitsportfolioofintellectualproperty.Ingene...,stechnologyanduseofassetmetainformationtocontrolr...
(Date:11/25/2009)...Newswire-FirstCall/--HeskaCorporation(HSKA);("Hesk...altyproductstotheveterinaryindustry,announcedtoday...plyofbloodgasproductsandaffiliatedconsumablesforth....com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "Hesk...dofadvancedpoint-of-carediagnostics,"commentedMich...
(Date:11/25/2009)...ire/--BioTrendsResearchGroup,Inc.releasedWave1ofit...amulti-phasesyndicatedmarketresearchprojecttrackin...ductlaunchthroughthefirstsixmonthsofavailability.E...rom75uniqueDermatologistsandqualitativeinformation...ra,obstaclestouse,typicalpatienttypes,productperce...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 1DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 2DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v Levine and Pandemic Influenza 48072 3Government of Canada announces funding for research on the H1N1 flu virus 8732 1Government of Canada announces funding for research on the H1N1 flu virus 8732 2Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 1Ludwig Institute of Cancer Research Ltd Brussels Branch Issues Statement Concerning Prospect Therapeutics Incs GCS 100 Molecule 48071 2
...x S.A.,(Eurolist: COX) today announced that Merck ... planned clinical studies, in mild to moderate,hyp...tive agreement to,develop new nitric oxide-donatin...technology. Three drug candidates have now been se... of which two have completed initial,dose ranging ...
...n Prevention Business, DUBLIN, Ohio, May 12 Card...vices that improve the safety and,productivity of ...acquisition of assets of privately held Enturia, I...ucts sold under the ChloraPrep(R) brand name., Ch... hospitals and,surgery centers as a patient preope...
Other Medicine Technology:NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3Cardinal Health Completes Enturia Acquisition 2
(Date:11/27/2009)...cialist manufacturers who use medical load cells a...of dollars by bringing in technology partner Flint... of pro-active medical manufacturers are calling i...f their projects, ensuring that progress will not ...entially outdated technology. , ...
(Date:11/26/2009)...g tetrathiomolybdate (TM) has been shown in studie...se, a disease caused by an overload of copper, and...ery little, however, is known about how the drug w...y Northwestern University researchers now has prov...ucture of TM bound to copper-loaded metallochapero...
(Date:11/26/2009)...earch Triangle Dental (RTDental), a leading dental...nnounced the expansion of its services to include ...g Macmillan. , Durham,... to announce that Dr. Doug Macmillan, an experienc...tional advanced training seminar. RTDental’...
(Date:11/25/2009)....25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,I...hosttwoinvestoreventsinDecember: ,, ASHBriefi... ,, Principalinvestigatorswilldiscussdatapres...ractorymultiplemyeloma,asfeaturedatthe51stAmerican...inNewOrleans,LA.Theteleconferencewillbeginat9:00a....
(Date:11/25/2009)...ewswire-USNewswire/--TheBlackAIDSInstituterecently...adershipfor2010. ,, ThenewBoardMembersareahighl...y,law,finance,governmenthealthprograms,editorial,a...iderangeofpersonalbackgroundsincludingbothheterose...lves,andrepresentingmultipleagegroups. ,, (Phot...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... of Switzerland finds children who are exposed to ... also have asthma or allergies. Researchers had pa...ires// regarding asthma and hay fever. They also t...r levels of endotoxin, a component of the cell wal...
...hen it comes to health issues. In California, trav...o smoke for residents. Environmental tobacco smoke...nge of adverse health effects - from exacerbation ...sity of California have studied a group of 200 peo...
... with mood disorders who have attempted suicide ar...ll. The link is especially strong among those who ...suffer from mood disorders themselves. Resear...people at especially high risk. Researchers from t...
...tion may unclog a mechanical heart pump, reconditi...researcher from University Hospital in Germany,// ...ous problem for heart failure patients who receive...pumping ability of a heart that can't dynamically ...
...preventable cause of death. Turning off the televi...w study finds the more an adolescent watches telev...//The risk of disease increases the earlier in lif...ising on television, smoking is still widespread o...
...th a higher dose of radiotherapy, with weekends o...involves a daily dose of radiotherapy five days a ...n found from a more intensive programme known as C... computer models, they suggested that a higher dos...
Other Medicine News:
Gamma GT (GLUPA)
Creatine Kinase (CK-NAC) SZASZ
Cholesterol (CHOD-PAP) (DIMENSION)
Cholesterol (Liquid)
Medicine Products: